AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial - Reuters

Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial - Reuters

Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial Reuters

September 3, 2026 at 01:54 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

United States

Tags

angelman syndrome biotech drug trial pharmaceutical pharmaceuticals trial failure Ultragenyx

All Coverage

Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQRVVnMDdHSDRwc0ttZzdJZS1GcVhfS0MzcFUwRnRxQXFZZmV4TS1SNFU0Zk41N0FQb0M3VGNWOGpRMDFEclJlNWlJSEZYSUFUQzh2OEJ5M0VDZXEyZHFudnVINVE2TElIclRBSDRpc09ybE5uN0llcmFtVHFJXzRkU28xcWlkWmtoTmxlVDBLRlJ6Y2x0dHMzUjJMUmlzdzZMcXZCSDlac1FPNlZ4OTZMazB6YUYySjFfd3g5TlduaF9oMGsyTm1UcjI2TVIyYjNGRUkwQ3pybmxWcjkyd1FITXlR?oc=5" target="_blank">Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

UniQure plunges as Huntington's trial data disappoints investors - reuters.com

UniQure plunges as Huntington's trial data disappoints investors reuters.com

September 29, 2026 at 10:11 PM

Experimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters

Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters

September 30, 2026 at 05:34 PM

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com

September 30, 2026 at 10:30 PM

AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters

AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters

October 2, 2026 at 06:58 AM

BioNTech to shutter three sites in Germany as no buyers emerge - Reuters

BioNTech to shutter three sites in Germany as no buyers emerge Reuters

September 28, 2026 at 08:00 PM

Lilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com

Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com

September 29, 2026 at 10:15 PM